triamterene has been researched along with Chronic Kidney Diseases in 2 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both amiloride and triamterene significantly reduced proteinuria in patients with proteinuric kidney disease." | 9.41 | The Effect of Amiloride on Proteinuria in Patients with Proteinuric Kidney Disease. ( Alshehri, M; Desale, S; Shen, W; Wilcox, C, 2021) |
| "Both amiloride and triamterene significantly reduced proteinuria in patients with proteinuric kidney disease." | 5.41 | The Effect of Amiloride on Proteinuria in Patients with Proteinuric Kidney Disease. ( Alshehri, M; Desale, S; Shen, W; Wilcox, C, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shen, W | 1 |
| Alshehri, M | 1 |
| Desale, S | 1 |
| Wilcox, C | 1 |
| Nasr, SH | 1 |
| Milliner, DS | 1 |
| Wooldridge, TD | 1 |
| Sethi, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Crossover Pilot Study of the Effect of Amiloride on Proteinuria in Patients With Proteinuric Kidney Disease[NCT02522650] | Phase 4 | 30 participants (Anticipated) | Interventional | 2013-07-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for triamterene and Chronic Kidney Diseases
| Article | Year |
|---|---|
The Effect of Amiloride on Proteinuria in Patients with Proteinuric Kidney Disease.
Topics: Adult; Aged; Amiloride; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; | 2021 |
1 other study available for triamterene and Chronic Kidney Diseases
| Article | Year |
|---|---|
Triamterene crystalline nephropathy.
Topics: Antihypertensive Agents; Biopsy; Creatinine; Diagnostic Errors; Drug Combinations; Drug-Related Side | 2014 |